Editorial : "Cardiotoxicity Induced by Radiotherapy and/or Chemotherapy After Cancer Treatment "

Marjan Boerma (1) , Omid Azimzadeh (2) , Nadia Pasinetti (3) , Virginie Monceau (4)

1 UAMS - University of Arkansas for Medical Sciences
2 BfS - Bundesamt für Strahlenschutz - Federal Office for Radiation Protection
3 UniBs - Università degli Studi di Brescia = University of Brescia
4 IRSN/PSE-SANTE/SESANE/LRTOX - Laboratoire de radiotoxicologie et radiobiologie expérimentale

It is our privilege to present 11 articles in this Frontiers Oncology Research Topic on "cardiotoxicity induced by radiotherapy and/or chemotherapy after cancer treatment". The therapeutic management of cancer has progressed over the last 10 years and has led to a significant increase in patient survival rates. Radiotherapy (RT) is classically applied in multiple fractions administered over several weeks to kill cancer while sparing normal tissue as much as possible. However, the corollary is the development of delayed toxicities that alter the quality of life of patients. Chemo- and/or RT-induced cardiovascular disease (CVD) is recognized as a worrisome side effect in patients with thoracic cancers.

Mots clés: advanced targeted therapy; cardiotoxicity; radiotherapy; cancer treatment

Domaines: Cancer

Marjan Boerma, Omid Azimzadeh, Nadia Pasinetti, Virginie Monceau. Editorial : "Cardiotoxicity Induced by Radiotherapy and/or Chemotherapy After Cancer Treatment ". Frontiers in Oncology, 2022, 12, ⟨10.3389/fonc.2022.1087928⟩. ⟨irsn-04072771⟩